LIFE SCIENCE ZURICH IMPACT CONFERENCE

On Monday, May 26th, 2025, at the Technopark Zurich, the fourth Life Science Zurich Impact Conference will take place. This time it’s all about «Precision Medicine and AI Innovations».

Save the date or register already today!

After three very successful LSZ Impact conferences in 2018, 2020 and 2023 the fourth event will again include keynotes and parallel sessions, 1:1 partnering meetings and an industry exhibition. For more information about the conference, visit the website.

Save the date and register now online and be part of the conference as a participant, project presenter, investor, sponsor, or exhibitor.


The future of precision medicine and artificial intelligence (AI) is poised to revolutionize healthcare by providing more personalized, efficient, and effective treatments. The aim of the conference is to discuss the opportunities and challenges in the field, and to demonstrate how AI and precision medicine are advancing our knowledge and helping to solve challenging health problems.


Hand in your abstract and be part of the programme!

The parallel sessions will cover topics revolving around the theme «Precision Medicine and AI Innovations», such as diagnostics, drug and therapy developments, gender medicine, and technology platforms. We invite researchers from academia and industry to present their translational projects or early-stage start-ups to potential collaboration partners and to seize the opportunity for accelerating the transition of new insights and developments from research to novel technologies.

Speak at the conference and benefit from:

  • a platform to present your project
  • networking with potential collaboration partners, investors, and peers

To present your project at a parallel session please submit title and abstract (maximum 400 words) of your talk by January 15th, 2025 to silvie.cuperus@lifescience.uzh.ch

We look forward to welcoming you to the next Life Science Zurich Impact Conference.

Kind regards,

Dr. Silvie Cuperus, Director Life Science Zurich

Mario Jenni, CEO Bio-Technopark Schlieren-Zurich

Danielle Spichiger, Director Life Sciences at Business & Economic
Development of the Canton of Zurich

back